Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX)

ClinicalTrials.gov ID: NCT00105976

Public ClinicalTrials.gov record NCT00105976. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-Blind, Parallel, Placebo-Controlled, Randomized Study to Evaluate the Efficacy and Safety of 3 Different Dose Levels (2.5, 7.5 and 20 mg) of MM-093 in Patients With Active Rheumatoid Arthritis on Stable Doses of Methotrexate

Study identification

NCT ID
NCT00105976
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Merrimack Pharmaceuticals
Industry
Enrollment
260 participants

Conditions and interventions

Interventions

  • MM-093 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2005
Primary completion
Not listed
Completion
Not listed
Last update posted
Jul 10, 2008

Started 2005

United States locations

U.S. sites
38
U.S. states
21
U.S. cities
36
Facility City State ZIP Site status
University of Alabama Birmingham Alabama 35294
Montgomery Rheumatology Associates Montgomery Alabama 36111
Arizona Arthritis Research, PLC Paradise Valley Arizona 85253
ArthroCare, Arthritis Care and Research, Inc. Phoenix Arizona 85012
Radiant Research Scottsdale Arizona 85251
Arthritis Medical Center of the Central Coast Santa Maria California 93454
Boling Clinical Trials Upland California 91786
National Jewish Medical and Research Center Denver Colorado 80206
Denver Arthritis Clinic Denver Colorado 80230
New England Research Associates Bridgeport Connecticut 06606
Arthritis and Rheumatic Disease Specialties Aventura Florida 33180
Renstar Medical Research Ocala Florida 34471
International Medical Research Ormond Beach Florida 32174
Sarasota Arthritis Research Center Sarasota Florida 34239
Center for Arthritis and Rheumatic Diseases South Miami Florida 33143
Coeur d'Alene Arthritis Clinic Coeur d'Alene Idaho 83814
Illinois Bone and Joint Institute Morton Grove Illinois 60016
The Arthritis Center Springfield Illinois 62704
Deerbrook Medical Associates Vernon Hills Illinois 60061
Rheumatology Associates, PC Indianapolis Indiana 46260
Wichita Clinic Wichita Kansas 67208
Rx Trials, Inc. Columbia Maryland 21045
Arthritis Center of Nebraska Lincoln Nebraska 68516
Arthritis Center of Reno Reno Nevada 89502
Arthritis, Osteoporosis & Musculoskeletal Disease Center Concord New Hampshire 03301
Arthritis Health Associates Syracuse New York 13210
Asheville Rheumatology and Osteoporosis Research Associates, Inc Asheville North Carolina 28801
Arthritis Clinic and Carolina Bone and Joint PA Charlotte North Carolina 28210
CARE Center Raleigh North Carolina 27609
North Carolina Arthritis and Allergy Care Center Raleigh North Carolina 27609
Veterans Administration Research Services Cincinnati Ohio 45220
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Rheumatic Disease Associates Willow Grove Pennsylvania 19090
The Arthritis Group Memphis Tennessee 38104
Austin Rheumatology Research Austin Texas 78705
Houston Institute for Clinical Research Houston Texas 77074
Arthritis and Osteoporosis Clinic Waco Texas 76708
University of Utah Division of Rheumatology Salt Lake City Utah 84132

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00105976, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 10, 2008 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00105976 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →